![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61P 35/00 | |
A61K 31/455 | |||
A61K 38/06 | |||
A61K 31/285 | |||
A61K 31/60 |
(11) | Patento numeris | 2321012 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 09808635.8 |
Europos patento paraiškos padavimo data | 2009-08-14 | |
(97) | Europos patento paraiškos paskelbimo data | 2011-05-18 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-10 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2009/053858 |
Data | 2009-08-14 |
(87) | Numeris | WO 2010/021928 |
Data | 2010-02-25 |
(30) | Numeris | Data | Šalis |
189511 P | 2008-08-20 | US |
(72) |
SCHWARTZ, Brian, Eric, US
LEWIS, Jonathan, US
KOMARNITSKY, Philip, B., US
|
(73) |
Solasia Pharma K.K.,
4F, Sumitomo Fudosan Shiba-koen Tower 2-11-1 Shiba-koen Minato-ku, Tokyo 105-0011,
JP
|
(54) | ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER |
ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER |